<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Calcium entry blockers are usually used to control <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> in patients with <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> due to <z:hpo ids='HP_0002617'>aneurysm</z:hpo> rupture </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, it's appeared that the dose of <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> required to decrease blood pressure is higher when calcium entry blockers are used </plain></SENT>
</text></document>